T-cell receptor (TCR) specific for H5 influenza hemagglutinin peptides (H5-specific TCR)

The CD8+ T-cell receptor (TCR) specific for H5-derived peptides is a pivotal mediator of the cellular immune response against highly pathogenic avian influenza (HPAI) H5N1 viruses. These receptors specifically bind to viral epitopes, such as those derived from the hemagglutinin (HA) protein, when they are cross-presented on MHC class I molecules by dendritic cells (Valkenburg et al., 2014). This interaction is fundamental for the activation of cytotoxic T lymphocytes (CTLs), which provide a defense mechanism by killing virus-infected cells and secreting antiviral cytokines like IFN-gamma (Gras et al., 2010). In therapeutic contexts, these TCRs are targeted through vaccine strategies designed to induce long-lasting T-cell memory or via TCR-engineered T-cell therapies for severe infections. Because T-cell epitopes are often more conserved than antibody-binding sites, targeting these receptors offers a potential strategy for broad protection against drifting H5 strains (Rimmelzwaan et al., 2007). However, the clinical application is constrained by MHC restriction, primarily HLA-A*02:01 in many studies, and the risk of immunopathology if the T-cell response is over-activated. Understanding the structural basis of this TCR-pMHC interaction is vital for improving the precision of immunotherapies and monitoring vaccine efficacy.

Other names

H5N1-specific T-cell receptorAvian influenza-specific CD8+ TCRH5-HA-specific TCRH5-peptide-MHC complex-specific TCR

Recognition of viral peptides presented on MHC class I molecules by CD8+ T cells, triggering intracellular signaling cascades that lead to the release of cytotoxic granules (perforin/granzyme) and inflammatory cytokines to eliminate infected cells (Gras et al., 2010).